References
- Berke R, Singh A, Guralnick M. Atopic dermatitis: an overview. Am Fam Physician. 2012;86(1):35–42.
- Bennington-Castro J, Eczema RR. (Atopic dermatitis): symptoms, treatment, causes, more. EverydayHealth; 2021. [cited 2021 Aug 19]. Available from: https://www.everydayhealth.com/eczema/guide/
- National Institute of Arthritis and Musculoskeletal and Skin Diseases. Atopic dermatitis. 2019. [cited 2021 Aug 19]. Available from: https://www.niams.nih.gov/health-topics/atopic-dermatitis
- Mayo Clinic. Atopic dermatitis (eczema) - symptoms and causes. 2020. [cited 2021 Aug 19]. Available from: https://www.mayoclinic.org/diseases-conditions/atopic-dermatitis-eczema/symptoms-causes/syc-20353273
- Boothe WD, Tarbox JA, Tarbox MB. Atopic dermatitis: pathophysiology. In: Management of atopic dermatitis. Basel: International Publishing AG; 2017. p. 21–37.
- Thomsen SF. Atopic dermatitis: natural history, diagnosis, and treatment. Int Sch Res Notices. 2014;2014:1–7.
- Umeki S. Allergic cycle: relationships between asthma allergic rhinitis, and atopic dermatitis. J Asthma. 1994;31(1):19–26.
- Lowe AJ, Carlin JB, Bennett CM, et al. Do boys do the atopic march while girls dawdle? J Allergy Clin Immunol. 2008;121(5):1190–1195.
- Chu H, Shin JU, Park CO, et al. Clinical diversity of atopic dermatitis: a review of 5,000 patients at a single institute. Allergy Asthma Immunol Res. 2017;9(2):158–168.
- Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol. 2000;136(6):763–769.
- Chopra R, Vakharia PP, Sacotte R, et al. Relationship between EASI and SCORAD severity assessments for atopic dermatitis. J Allergy Clin Immunol. 2017;140(6):1708–1710.e1.
- Chopra R, Vakharia P, Sacotte R, et al. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol. 2017;177(5):1316–1321.
- Mayo Clinic. Atopic dermatitis (eczema) - diagnosis and treatment. 2020. [cited 2021 Aug 19]. Available from: https://www.mayoclinic.org/diseases-conditions/atopic-dermatitis-eczema/diagnosis-treatment/drc-20353279
- Lyons JJ, Milner JD, Stone KD. Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am. 2015;35(1):161–183.
- Zeppa L, Bellini V, Lisi P. Atopic dermatitis in adults. Dermatitis. 2011;22(1):40–46.
- Ibekwe P, Ukonu B. Impact of weather conditions on atopic dermatitis prevalence in Abuja, Nigeria. J Natl Med Assoc. 2019;111(1):88–93.
- Rajka G. Atopic dermatitis: correlation of environmental factors with frequency. Int J Dermatol. 1986;25(5):301–304.
- Urban K, Chu S, Giesey RL, et al. The global, regional, and national burden of atopic dermatitis in 195 countries and territories: an ecological study from the Global Burden of Disease Study 2017. JAAD Int. 2021;2:12–18.
- Mann C, Dreher M, Weeß H-G, et al. Sleep disturbance in patients with urticaria and atopic dermatitis: an underestimated burden. Acta Derm Venereol. 2020;100(6):adv00073.
- Carroll CL, Balkrishnan R, Feldman SR, et al. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol. 2005;22(3):192–199.
- Buys LM. Treatment options for atopic dermatitis. Am Fam Physician. 2007;75(4):523–528.
- Weston WL, Howe W. Treatment of atopic dermatitis (eczema). UptoDate [updated 2018 Oct 9; cited 2018 Oct 18]; 2020.
- Ratchataswan T, Banzon TM, Thyssen JP, et al. Biologics for treatment of atopic dermatitis: current status and future prospect. J Allergy Clin Immunol Pract. 2021;9(3):1053–1065.
- Reed B, Blaiss MS. The burden of atopic dermatitis. Allergy Asthma Proc. 2018;39(6):406–410.
- Ring J, Zink A, Arents B, et al. Atopic eczema: burden of disease and individual suffering–results from a large EU study in adults. J Eur Acad Dermatol Venereol. 2019;33(7):1331–1340.
- Eichenfield LF, Stein Gold LF. The disease burden of atopic dermatitis. Semin Cutan Med Surg. 2017;36(4S):S92–S94.
- Alqahtani JM. Atopy and allergic diseases among Saudi young adults: a cross-sectional study. J Int Med Res. 2020;48(1):300060519899760.
- Alzolibani AA. Impact of atopic dermatitis on the quality of life of Saudi children. Saudi Med J. 2014;35(4):391–396.
- Al-Afif KAM, Buraik MA, Buddenkotte J, et al. Understanding the burden of atopic dermatitis in Africa and the Middle East. Dermatol Ther (Heidelb). 2019;9(2):223–241.
- Binyamin ST, Algamal F, Yamani AN, et al. Prevalence and determinants of eczema among females aged 21 to 32 years in Jeddah city–Saudi Arabia. Our Dermatol Online. 2017;8(1):22–26.
- World Health Organization. Adolescent health: World Health Organization; 2021. [cited 2021 Aug 23]. Available from: https://www.who.int/southeastasia/health-topics/adolescent-health#:∼:text=WHO%20defines%20'Adolescents’%20as%20individuals,15%2D24%20year%20age%20group
- Gold MR, Stevenson D, Fryback DG. HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population health. Annu Rev Public Health. 2002;23:115–134.
- Anderson P, Phillips C. What is a QALY. Newmarket (UK): Hayward Medical Communications; 2009.
- Parthasaradhi A, Al Gufai AF. The pattern of skin diseases in hail region, Saudi Arabia. Ann Saudi Med. 1998;18(6):558–561.
- Alshamrani HM, Alsolami MA, Alshehri AM, et al. Pattern of skin diseases in a university hospital in Jeddah, Saudi Arabia: age and sex distribution. Ann Saudi Med. 2019;39(1):22–28.
- Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222.
- Ghdx.healthdata.org. GBD Results Tool | GHDx: Institute for Health Metrics and Evaluation; 2021. [cited 2021 Aug 23]. Available from: http://ghdx.healthdata.org/gbd-results-tool.
- Ezzedine K, Shourick J, Merhand S, et al. Impact of atopic dermatitis in adolescents and their parents: a French study. Acta Derm Venereol. 2020;100(17):adv00294–3653.
- Beikert F, Langenbruch A, Radtke M, et al. Willingness to pay and quality of life in patients with atopic dermatitis. Arch Dermatol Res. 2014;306(3):279–286.
- DLQI to EQ-5D tool. [cited 2021 Aug 23]. Available from: https://dlqi.broadstreetheor.com.
- Automeris.io. WebPlotDigitizer - extract data from plots, images, and maps. 2021. [cited 2021 Aug 23]. Available from: https://automeris.io/WebPlotDigitizer.
- Fasseeh AN, Elezbawy B, Korra N, et al. Burden of atopic dermatitis in adults and adolescents: a systematic literature review. Dermatol Ther. 2022;12(12):2653–2668.
- Andersen L, Nyeland M, Nyberg F. Higher self‐reported severity of atopic dermatitis in adults is associated with poorer self‐reported health‐related quality of life in France, Germany, the UK and the USA. Br J Dermatol. 2020;182(5):1176–1183.
- Le PH, Vo TQ, Nguyen NH. Quality of life measurement alteration among Vietnamese: impact and treatment benefit related to eczema. J Pak Med Assoc. 2019;69(6):S49–S56.
- Lee SH, Lee SH, Lee SY, et al. Psychological health status and health-related quality of life in adults with atopic dermatitis: a nationwide cross-sectional study in South Korea. Acta Derm Venereol. 2018;98(1):89–97.
- Misery L, Seneschal J, Reguiai Z, et al. The impact of atopic dermatitis on sexual health. J Eur Acad Dermatol Venereol. 2019;33(2):428–432.
- Katoh N, Saeki H, Kataoka Y, et al. Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS‐J): baseline characteristics, treatment history and disease burden. J Dermatol. 2019;46(4):290–300.
- Janssen M, Szende A, Cabases J, et al. Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries. Eur J Health Econ. 2019;20(2):205–216.
- Mitchell RJ, Bates P. Measuring health-related productivity loss. Popul Health Manag. 2011;14(2):93–98.
- Saudi Food & Drug Authority. Drugs list; 2021. [cited 2021 23 August]. Available from: https://www.sfda.gov.sa/en/drugs-list
- Nahdionline.com. Nahdi Online Pharmacy. 2021. [cited 2021 Aug23]. Available from: www.nahdionline.com/en/
- Noon online shopping. 2021. [cited 2021 Aug 23]. Available from: www.noon.com/saudi-en.
- AlGhamdi KM, Khurram H, Taïeb A. Survey of dermatologists’ phototherapy practices for vitiligo. Indian J Dermatol Venereol Leprol. 2012;78(1):74.
- Inflationtool.com. SAR Inflation Calculator - Saudi Riyal (1996–2021). 2021. [cited 2021 Aug 23]. Available from: www.inflationtool.com/saudi-arabian-riyaln.
- Ministry of Health KoSA, World Health Organization, EMRO. WHO STEPwise approach to NCD surveillance country‐specific STANDARD REPORT Saudi Arabia; 2005. [cited 2021 Aug 23]. Available from: https://www.who.int/publications/m/item/2005-steps-country-report-saudi-arabia-english
- Hanifin JM, Reed ML, Prevalence E, et al. A population-based survey of eczema prevalence in the United States. Dermatitis. 2007;18(2):82–91.
- General Authority for Statistics. Labor Force. 2020. [cited 2021 Aug 24]. Available from: www.stats.gov.sa/en/814
- Numbeo.com. Rankings by Country of Average Monthly Net Salary (After Tax) (Salaries And Financing). 2021. [cited 2021 Aug 24]. Available from: www.numbeo.com/cost-of-living/country_price_rankings?itemId=105
- World Health Organization. Global Health Observatory (GHO). 2021. [cited 2021 Aug 24] Available from: https://www.who.int/data/gho
- Data.worldbank.org. GDP (current US$) - Saudi Arabia | Data. 2019. (Data.worldbank.org). Available from: https://data.worldbank.org/indicator/NY.GDP.MKTP.CD?locations=SA
- Laughter M, Maymone M, Mashayekhi S, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017. Br J Dermatol. 2021;184(2):304–309.
- Launois R, Ezzedine K, Cabout E, et al. Importance of out-of-pocket costs for adult patients with atopic dermatitis in France. J Eur Acad Dermatol Venereol. 2019;33(10):1921–1927.
- Zink AGS, Arents B, Fink-Wagner A, et al. Out-of-pocket costs for individuals with atopic eczema: a cross-sectional study in nine European countries. Acta Derm Venereol. 2019;99(3):263–267.
- Fasseeh A, Karam R, Jameleddine M, et al. Implementation of health technology assessment in the Middle East and North Africa: comparison between the current and preferred status. Front Pharmacol. 2020;11:15.
- Alghamdi A, Balkhi B, Alqahtani S, et al. The economic burden associated with the management of different stages of breast cancer: a retrospective cost of illness analysis in Saudi Arabia. Healthcare (Basel). 2021;9(7):907.